Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Davenport

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oncoscience|June 2, 2018
Programming a serial killer: CAR T cells form non-classical immune synapsesAlexander J Davenport, Misty R Jenkins
Clinical & Translational Immunology|February 12, 2015
Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoproteinRyan S Cross, Jordane Malaterre, Alexander J Davenport, et al.
European Journal of Immunology|September 10, 2022
Super-killer CTLs are generated by single gene deletion of Bach2Philippa R Barton, Alexander J Davenport, Jens Hukelmann, et al.
Oncoimmunology|November 21, 2015
CAR-T cells are serial killersAlexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responsesLeesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Neuro-Oncology Advances|May 8, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie S Wang, Alexander J Davenport, Melinda Iliopoulos, et al.
Oncotarget|February 1, 2018
An ultrastructural investigation of tumors undergoing regression mediated by immunotherapyJennifer A Westwood, Sarah Ellis, Jill Danne, et al.
Frontiers in Oncology|August 28, 2023
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine gliomaKirti Pandey, Stacie S Wang, Nicole A Mifsud, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncoscience|June 2, 2018
Programming a serial killer: CAR T cells form non-classical immune synapsesAlexander J Davenport, Misty R Jenkins
Clinical & Translational Immunology|February 12, 2015
Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoproteinRyan S Cross, Jordane Malaterre, Alexander J Davenport, et al.
European Journal of Immunology|September 10, 2022
Super-killer CTLs are generated by single gene deletion of Bach2Philippa R Barton, Alexander J Davenport, Jens Hukelmann, et al.
Oncoimmunology|November 21, 2015
CAR-T cells are serial killersAlexander J Davenport, Misty R Jenkins, David S Ritchie, et al.
Journal for Immunotherapy of Cancer|August 7, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responsesLeesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Neuro-Oncology Advances|May 8, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie S Wang, Alexander J Davenport, Melinda Iliopoulos, et al.
Oncotarget|February 1, 2018
An ultrastructural investigation of tumors undergoing regression mediated by immunotherapyJennifer A Westwood, Sarah Ellis, Jill Danne, et al.
Frontiers in Oncology|August 28, 2023
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine gliomaKirti Pandey, Stacie S Wang, Nicole A Mifsud, et al.
Pageof 2